NCT05566262View on ClinicalTrials.gov

Bodewell Products for the Treatment of Atopic Dermatitis

PHASE4RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Atopic Dermatitis
Interventions
DRUG

Bodewell Calming Cream

Bodewell is a non-prescription and contains 22 botanical ingredients in addition to colloidal oatmeal.

Trial Locations (1)

35233

RECRUITING

The University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

University of Alabama at Birmingham

OTHER